Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Treasury Shares: 2021-2025

Historic Treasury Shares for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $2.2 million.

  • Kiniksa Pharmaceuticals International's Treasury Shares fell 7.68% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 7.68%. This contributed to the annual value of $2.3 million for FY2024, which is 6.10% down from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Treasury Shares stood at $2.2 million, which was down 3.10% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Treasury Shares ranged from a high of $2.4 million in Q4 2023 and a low of $495,773 during Q2 2021.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Treasury Shares had a median value of $2.3 million in 2024 and averaged $2.2 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 148.75% in 2023, then decreased by 7.68% in 2025.
  • Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Treasury Shares stood at $885,021 in 2021, then skyrocketed by 96.88% to $1.7 million in 2022, then skyrocketed by 37.56% to $2.4 million in 2023, then declined by 6.10% to $2.3 million in 2024, then decreased by 7.68% to $2.2 million in 2025.
  • Its Treasury Shares was $2.2 million in Q3 2025, compared to $2.3 million in Q2 2025 and $2.1 million in Q1 2025.